Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up-Reference-Cited by-同舟云学术

Safety of a quadrivalent human papillomavirus vaccine in a Phase 3, randomized, double-blind, placebo-controlled clinical trial among Chinese women during 90 months of follow-up

Published:2019-02 Issue:6 Volume:37 Page:889-897
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Chen Wen,Zhao Yun,Xie Xing,Liu Jihong,Li Jingran,Zhao Chao,Wang Shaoming,Liao Xueyan,Shou Qiong,Zheng Minghuan,Saah Alfred J,Wei Lihui,Qiao Youlin^ORCID

Funder

Merck & Co., Inc.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference32 articles.

1. Worldwide burden of cancer attributable to HPV by site, country and HPV type;de Martel;Int J Cancer,2017

2. International Agency for Research on Cancer. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012, ; 2012 [accessed June 1, 2018].

3. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study;de Sanjose;Lancet Oncol,2010

4. Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, et al. Human papillomavirus and related diseases report: China. Summary report, ; 2017 [accessed June 1, 2018].

5. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine;Garland;J Infect Dis,2009

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and challenges for human papillomavirus vaccination in China;Human Vaccines & Immunotherapeutics;2024-04-04

2. Post-marketing safety surveillance study of a 9-valent human papillomavirus vaccine in individuals aged 16–26 years in Chongqing, China;Human Vaccines & Immunotherapeutics;2023-12-15

3. Tackling barriers to scale up human papillomavirus vaccination in China: progress and the way forward;Infectious Diseases of Poverty;2023-09-21

4. Association of periconceptional or pregnancy exposure of HPV vaccination and adverse pregnancy outcomes: a systematic review and meta-analysis with trial sequential analysis;Frontiers in Pharmacology;2023-05-09

5. Public School Adolescents Had Increased Odds of Being Willing to Uptake HPV Vaccinations Owing to Sociodemographic and Healthcare Access Features in Bahir Dar City, Ethiopia;BioMed Research International;2023-04-12